Administration in a Hypotonic Solution Is Preferable to Dose Escalation in Intraperitoneal Cisplatin Chemotherapy for Peritoneal Carcinomatosis in Rats

Publisher： Karger

E-ISSN： 1423-0232|57|1|77-82

ISSN： 0030-2414

Source： Oncology, Vol.57, Iss.1, 1999-07, pp. : 77-82

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human Pharmacokinetic Study of Heated Intraperitoneal Oxaliplatin in Increasingly Hypotonic Solutions after Complete Resection of Peritoneal Carcinomatosis

By  

Oncology, Vol. 63, Iss. 4, 2002-11 ,pp. : 346-352

Karger

Access to resources Recommend Favorite

Urachal Carcinoma with Choroidal, Lung, Lymph Node, Adrenal, Mammary, and Bone Metastases and Peritoneal Carcinomatosis Showing Partial Response after Chemotherapy Treatment with a Modified Docetaxel, Cisplatin and 5-Fluorouracil Regimen

By  

Case Reports in Oncology, Vol. 9, Iss. 1, 2016-04 ,pp. : 216-222

Karger

Access to resources Recommend Favorite

Complete Response of Highly Advanced Gastric Cancer with Peritoneal Dissemination after New Combined Chemotherapy of S-1 and Low-Dose Cisplatin: Report of a Case

By  

Oncology, Vol. 61, Iss. 1, 2001-07 ,pp. : 16-22

Karger

Access to resources Recommend Favorite

The results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1200 patients with peritoneal malignancy

By  

COLORECTAL DISEASE, Vol. 17, Iss. 9, 2015-09 ,pp. : 772-778

John Wiley & Sons Inc

Access to resources Recommend Favorite

High‐quality results of cytoreductive surgery and heated intraperitoneal chemotherapy perfusion for carcinomatosis at a low volume institution

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 112, Iss. 2, 2015-08 ,pp. : 219-224

John Wiley & Sons Inc

Access to resources Recommend Favorite